Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raymond SM Wong"'
Publikováno v:
Hong Kong Medical Journal. 28:413-414
Autor:
Michael Schaffer, Corey Casper, Raymond Sm Wong, Ming Qi, Rajesh Bandekar, Frits van Rhee, Helgi van de Velde, Brett Hall, Nikhil C. Munshi, Manjula Reddy, Jessica Vermeulen, Shalini Chaturvedi
Publikováno v:
Clinical Cancer Research. 21:4294-4304
Purpose: Siltuximab (IL6 antibody) is approved for the treatment of multicentric Castleman disease (MCD). Effects of IL6 inhibition on the inflammatory milieu accompanying MCD have not been characterized. Experimental Design: Trends in inflammatory-
Autor:
Lisa Tan, Mohamed Hamdani, Federico Grossi, Pimjai Niparuck, Surapol Issaragrisil, Eric Tse, Tontanai Numbenjapon, Pascal Deschatelets, Jameela Sathar, Humphrey Pullon, Cedric G. Francois, Raymond Sm Wong, Patrick W. Johnson
Publikováno v:
Blood. 132:2314-2314
Background: PNH is characterized by a degree of bone marrow failure and hemolysis resulting in debilitating hemolytic anemia and an increased risk of thrombosis. Uncontrolled complement activation leads to intravascular hemolysis mediated by the memb
Autor:
Erhard Quebe-Fehling, James B. Bussel, Raymond Sm Wong, Abdulgabar Salama, Mansoor N. Saleh, Ali El-Ali, Balkis Meddeb, Abderrahim Khelif
Publikováno v:
Blood. 128:1368-1368
Introduction: ITP, characterized by a reduction in platelets leading to thrombocytopenia, which persists for >12 months is considered chronic (cITP). Eltrombopag is an oral thrombopoietin receptor agonist approved for treatment of patients with cITP
Autor:
Balkis Meddeb, James B. Bussel, Mansoor N. Saleh, Abderrahim Khelif, Abdulgabar Salama, Raymond Sm Wong, Erhard Quebe-Fehling, Ali El-Ali
Publikováno v:
Blood. 128:4930-4930
Introduction: Eltrombopag is an oral thrombopoietin receptor agonist, approved for the treatment of patients with cITP (persisting >12 months) aged ≥1 year, who are refractory to other treatments (eg corticosteroids, immunoglobulins). Pharmacokinet
Autor:
Ming-Chih Chang, Liang Piu Koh, Wen-Li Hwang, Suporn Chuncharunee, Ponlapat Rojnuckarin, Shih-Chung Wang, Cheng-Shyong Chang, Surapol Issaragrisil, Raymond Sm Wong, Lalita Norasetthada, Anskar Y.H. Leung, Meng-Yao Lu, Kian Meng Chang, Kang Hsi Wu, Tsai Yun Chen
Publikováno v:
Blood. 126:1217-1217
Background Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine is the preferred treatment for patients with severe acquired aplastic anemia (SAA) ineligible for hematopoietic stem cell transplantation. In 2007, horse AT
Publikováno v:
Arthritis and rheumatism. 35(2)
Objective. To analyze HLA—DR and DQ associations with rheumatoid arthritis (RA) in patients from southern China. Methods. In 66 patients and 45 controls, restriction fragment length polymorphism studies were performed using DRB, DQA, and DQB probes